{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:12:35Z","timestamp":1790705555025,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T00:00:00Z","timestamp":1480464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01NS078307"],"award-info":[{"award-number":["R01NS078307"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UH4TR000491"],"award-info":[{"award-number":["UH4TR000491"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R42MH093302"],"award-info":[{"award-number":["R42MH093302"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21HD057256"],"award-info":[{"award-number":["R21HD057256"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS43284"],"award-info":[{"award-number":["R01NS43284"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12987-016-0045-y","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T14:22:32Z","timestamp":1480515752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers"],"prefix":"10.1186","volume":"13","author":[{"given":"Aaron","family":"Dadas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolewis","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9645-0318","authenticated-orcid":false,"given":"Damir","family":"Janigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,30]]},"reference":[{"issue":"1","key":"45_CR1","first-page":"5","volume":"83","author":"P Schiavi","year":"2012","unstructured":"Schiavi P, Laccarino C, Servadei F. The value of the calcium binding protein S100 in the management of patients with traumatic brain injury. Acta Biomed. 2012;83(1):5\u201320.","journal-title":"Acta Biomed"},{"key":"45_CR2","unstructured":"Janigro D, Barnett G, Mayberg M, Inventors. Peripheral marker of blood brain barrier permeability. US Patent 20030170747 A1. 2003. http:\/\/www.google.ch\/patents\/US20030170747 ."},{"issue":"11","key":"45_CR3","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/cncr.11409","volume":"97","author":"AA Kanner","year":"2003","unstructured":"Kanner AA, Marchi N, Fazio V, Mayberg MR, Koltz MT, Siomin V, et al. Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions. Cancer. 2003;97(11):2806\u201313.","journal-title":"Cancer"},{"issue":"1\u20132","key":"45_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0006-8993(02)02586-6","volume":"940","author":"M Kapural","year":"2002","unstructured":"Kapural M, Krizanac-Bengez L, Barnett G, Perl J, Masaryk T, Apollo D, et al. Serum S-100beta as a possible marker of blood-brain barrier disruption. Brain Res. 2002;940(1\u20132):102\u20134.","journal-title":"Brain Res"},{"issue":"3\u20134","key":"45_CR5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/RNN-2003-00231","volume":"21","author":"N Marchi","year":"2003","unstructured":"Marchi N, Rasmussen PA, Kapural M, Fazio V, Cavaglia M, Janigro D. Peripheral markers of brain damage and blood-brain barrier dysfunction. Restorative Neurol Neurosci. 2003;21(3\u20134):109\u201321.","journal-title":"Restorative Neurol Neurosci"},{"issue":"2","key":"45_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1089\/neu.2015.4149","volume":"33","author":"RD Welch","year":"2016","unstructured":"Welch RD, Ayaz SI, Lewis LM, Unden J, Chen JY, Mika VH, et al. Ability of serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury. J Neurotrauma. 2016;33(2):203\u201314.","journal-title":"J Neurotrauma"},{"issue":"2","key":"45_CR7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0009-8981(01)00573-3","volume":"310","author":"H Reiber","year":"2001","unstructured":"Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta. 2001;310(2):173\u201386.","journal-title":"Clin Chim Acta"},{"key":"45_CR8","first-page":"1","volume":"11","author":"K Heidari","year":"2015","unstructured":"Heidari K, Vafaee A, Rastekenari AM, Taghizadeh M, Shad EG, Eley R, et al. S100B protein as a screening tool for computed tomography findings after mild traumatic brain injury: systematic review and meta-analysis. Brain Inj. 2015;11:1\u201312.","journal-title":"Brain Inj"},{"issue":"4","key":"45_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/ijc.1504","volume":"94","author":"G Ghanem","year":"2001","unstructured":"Ghanem G, Loir B, Morandini R, Sales F, Lienard D, Eggermont A, et al. On the release and half-life of S100B protein in the peripheral blood of melanoma patients. Int J Cancer. 2001;94(4):586\u201390.","journal-title":"Int J Cancer"},{"issue":"2","key":"45_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.psyneuen.2009.07.012","volume":"35","author":"J Steiner","year":"2010","unstructured":"Steiner J, Schiltz K, Walter M, Wunderlich MT, Keilhoff G, Brisch R, et al. S100B serum levels are closely correlated with body mass index: an important caveat in neuropsychiatric research. Psychoneuroendocrinology. 2010;35(2):321\u20134.","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"45_CR11","doi-asserted-by":"publisher","first-page":"e12691","DOI":"10.1371\/journal.pone.0012691","volume":"5","author":"N Pham","year":"2010","unstructured":"Pham N, Fazio V, Cucullo L, Teng Q, Biberthaler P, Bazarian JJ, et al. Extracranial sources of S100B do not affect serum levels. PLoS ONE. 2010;5(9):e12691.","journal-title":"PLoS ONE"},{"issue":"11","key":"45_CR12","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1681\/ASN.2009020171","volume":"20","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Levey AS. Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol. 2009;20(11):2305\u201313.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"45_CR13","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1523\/JNEUROSCI.23-05-01949.2003","volume":"23","author":"N Marchi","year":"2003","unstructured":"Marchi N, Fazio V, Cucullo L, Kight K, Masaryk TJ, Barnett G, et al. Serum transthyretin as a possible marker of blood-to-CSF barrier disruption. J Neurosci. 2003;23(5):1949\u201355.","journal-title":"J Neurosci"},{"issue":"4","key":"45_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/00003088-200847040-00004","volume":"47","author":"SA Peters","year":"2008","unstructured":"Peters SA. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis. Clin Pharmacokinet. 2008;47(4):261\u201375.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"45_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2165\/00003088-199835040-00001","volume":"35","author":"A Bernareggi","year":"1998","unstructured":"Bernareggi A. Clinical pharmacokinetics of nimesulide. Clin Pharmacokinet. 1998;35(4):247\u201374.","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"45_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF01062191","volume":"19","author":"A Bernareggi","year":"1991","unstructured":"Bernareggi A, Rowland M. Physiologic modeling of cyclosporin kinetics in rat and man. J Pharmacokinet Biopharm. 1991;19(1):21\u201350.","journal-title":"J Pharmacokinet Biopharm"},{"issue":"4","key":"45_CR17","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1528-1167.2007.00988.x","volume":"48","author":"N Marchi","year":"2007","unstructured":"Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N, et al. Seizure-promoting effect of blood-brain barrier disruption. Epilepsia. 2007;48(4):732\u201342.","journal-title":"Epilepsia"},{"issue":"21","key":"45_CR18","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1200\/JCO.2008.19.3789","volume":"27","author":"L Angelov","year":"2009","unstructured":"Angelov L, Doolittle ND, Kraemer DF, Siegal T, Barnett GH, Peereboom DM, et al. Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. J Clin Oncol. 2009;27(21):3503\u20139.","journal-title":"J Clin Oncol"},{"key":"45_CR19","unstructured":"Boron WF, Boulpaep EL. Glomerular filtration and renal blood flow. In: Medical physiology. Philadelphia, PA: Elsevier; 2003. p. 757\u201373."},{"issue":"5","key":"45_CR20","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/00006123-199805000-00082","volume":"42","author":"RA Kroll","year":"1998","unstructured":"Kroll RA, Neuwelt EA. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery. 1998;42(5):1083\u201399.","journal-title":"Neurosurgery"},{"key":"45_CR21","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1200\/JCO.1991.9.9.1580","volume":"9","author":"EA Neuwelt","year":"1991","unstructured":"Neuwelt EA, Goldman DL, Dahlborg SA, Crossen J, Ramsey F, Roman Goldstein S, et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol. 1991;9:1580\u201390.","journal-title":"J Clin Oncol"},{"issue":"3","key":"45_CR22","first-page":"581","volume":"15","author":"S Roman-Goldstein","year":"1994","unstructured":"Roman-Goldstein S, Clunie DA, Stevens J, Hogan R, Monard J, Ramsey F, et al. Osmotic blood-brain barrier disruption: CT and radionuclide imaging. AJNR Am J Neuroradiol. 1994;15(3):581\u201390.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"45_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1515\/cclm-2015-0771","volume":"54","author":"D Bouvier","year":"2016","unstructured":"Bouvier D, Duret T, Rouzaire P, Jabaudon M, Rouzaire M, Nourrisson C, et al. Preanalytical, analytical, gestational and pediatric aspects of the S100B immuno-assays. Clin Chem Lab Med. 2016;54(5):833\u201342.","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"45_CR24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/cncr.21220","volume":"104","author":"MA Vogelbaum","year":"2005","unstructured":"Vogelbaum MA, Masaryk T, Mazzone P, Mekhail T, Fazio V, McCartney S, et al. S100beta as a predictor of brain metastases: brain versus cerebrovascular damage. Cancer. 2005;104(4):817\u201324.","journal-title":"Cancer"},{"issue":"4","key":"45_CR25","first-page":"164","volume":"7","author":"P Biberthaler","year":"2002","unstructured":"Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Mutschler W, Linsenmaier U, et al. Rapid identification of high-risk patients after minor head trauma (MHT) by assessment of S-100B: ascertainment of a cut-off level. Eur J Med Res. 2002;7(4):164\u201370.","journal-title":"Eur J Med Res"},{"issue":"10","key":"45_CR26","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1681\/ASN.2008090980","volume":"20","author":"BC Astor","year":"2009","unstructured":"Astor BC, Levey AS, Stevens LA, Van LF, Selvin E, Coresh J. Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol. 2009;20(10):2214\u201322.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"45_CR27","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1373\/clinchem.2010.147827","volume":"56","author":"TH Hostetter","year":"2010","unstructured":"Hostetter TH, Levey AS, Stevens LA. Clinical impact of reporting estimated glomerular filtration rates. Clin Chem. 2010;56(9):1381\u20133.","journal-title":"Clin Chem"},{"issue":"5","key":"45_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/ki.2010.462","volume":"79","author":"LA Stevens","year":"2011","unstructured":"Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, et al. Evaluation of the chronic kidney disease epidemiology collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int. 2011;79(5):555\u201362.","journal-title":"Kidney Int"},{"issue":"3","key":"45_CR29","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00701-007-1489-2","volume":"150","author":"K Nylen","year":"2008","unstructured":"Nylen K, Ost M, Csajbok LZ, Nilsson I, Hall C, Blennow K, et al. Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochir (Wien). 2008;150(3):221\u20137.","journal-title":"Acta Neurochir (Wien)"},{"issue":"5","key":"45_CR30","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1373\/49.5.836","volume":"49","author":"AO Ben","year":"2003","unstructured":"Ben AO, Vally J, Adem C, Foglietti MJ, Beaudeux JL. Reference values for serum S-100B protein depend on the race of individuals. Clin Chem. 2003;49(5):836\u20137.","journal-title":"Clin Chem"},{"issue":"4","key":"45_CR31","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/ajpa.10092","volume":"118","author":"JS Allen","year":"2002","unstructured":"Allen JS, Damasio H, Grabowski TJ. Normal neuroanatomical variation in the human brain: an MRI-volumetric study. Am J Phys Anthropol. 2002;118(4):341\u201358.","journal-title":"Am J Phys Anthropol"},{"issue":"6","key":"45_CR32","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jpsychires.2013.03.001","volume":"47","author":"AL Morera-Fumero","year":"2013","unstructured":"Morera-Fumero AL, Abreu-Gonzalez P, Henry-Benitez M, Yelmo-Cruz S, Diaz-Mesa E. Summer\/winter changes in serum S100B protein concentration as a source of research variance. J Psychiatr Res. 2013;47(6):791\u20135.","journal-title":"J Psychiatr Res"},{"issue":"11","key":"45_CR33","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/j.1553-2712.2003.tb00605.x","volume":"10","author":"JJ Bazarian","year":"2003","unstructured":"Bazarian JJ, Pope C, McClung J, Cheng YT, Flesher W. Ethnic and racial disparities in emergency department care for mild traumatic brain injury. Acad Emerg Med. 2003;10(11):1209\u201317.","journal-title":"Acad Emerg Med"},{"issue":"7","key":"45_CR34","doi-asserted-by":"publisher","first-page":"e101477","DOI":"10.1371\/journal.pone.0101477","volume":"9","author":"E Bargerstock","year":"2014","unstructured":"Bargerstock E, Puvenna V, Iffland P, Falcone T, Hossain M, Vetter S, et al. Is peripheral immunity regulated by blood-brain barrier permeability changes? PLoS ONE. 2014;9(7):e101477.","journal-title":"PLoS ONE"},{"issue":"1","key":"45_CR35","first-page":"101","volume":"101","author":"L Weiss","year":"1980","unstructured":"Weiss L, Haydock K, Pickren JW, Lane WW. Organ vascularity and metastatic frequency. Am J Pathol. 1980;101(1):101\u201314.","journal-title":"Am J Pathol"},{"issue":"4","key":"45_CR36","doi-asserted-by":"publisher","first-page":"e62101","DOI":"10.1371\/journal.pone.0062101","volume":"8","author":"CA Mayer","year":"2013","unstructured":"Mayer CA, Brunkhorst R, Niessner M, Pfeilschifter W, Steinmetz H, Foerch C. Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases. PLoS ONE. 2013;8(4):e62101.","journal-title":"PLoS ONE"},{"key":"45_CR37","doi-asserted-by":"publisher","first-page":"28203","DOI":"10.1038\/srep28203","volume":"6","author":"S Mondello","year":"2016","unstructured":"Mondello S, Kobeissy F, Vestri A, Hayes RL, Kochanek PM, Berger RP. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein after pediatric traumatic brain injury. Sci Rep. 2016;6:28203.","journal-title":"Sci Rep."},{"key":"45_CR38","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nicl.2014.10.007","volume":"6","author":"E Orasanu","year":"2014","unstructured":"Orasanu E, Melbourne A, Cardoso MJ, Modat M, Taylor AM, Thayyil S, et al. Brain volume estimation from post-mortem newborn and fetal MRI. Neuroimage Clin. 2014;6:438\u201344.","journal-title":"Neuroimage Clin"},{"issue":"2","key":"45_CR39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0022-3476(59)80084-6","volume":"55","author":"TR Sisson","year":"1959","unstructured":"Sisson TR, Lund CJ, Whalen LE, Telek A. The blood volume of infants. I. The full-term infant in the first year of life. J Pediatr. 1959;55(2):163\u201379.","journal-title":"J Pediatr"},{"issue":"6","key":"45_CR40","doi-asserted-by":"publisher","first-page":"e11089","DOI":"10.1371\/journal.pone.0011089","volume":"5","author":"T Falcone","year":"2010","unstructured":"Falcone T, Fazio V, Lee C, Simon B, Franco K, Marchi N, et al. Serum S100B: a potential biomarker for suicidality in adolescents? PLoS ONE. 2010;5(6):e11089.","journal-title":"PLoS ONE"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-016-0045-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12987-016-0045-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-016-0045-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T23:15:02Z","timestamp":1749770102000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-016-0045-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,30]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["45"],"URL":"https:\/\/doi.org\/10.1186\/s12987-016-0045-y","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,30]]},"assertion":[{"value":"7 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"21"}}